For research use only. Not for therapeutic Use.
Flubrotizolam（Cat No.:I027572）is a synthetic benzodiazepine derivative that is structurally related to other compounds in the class, such as flubromazolam. It acts as a central nervous system depressant, exerting anxiolytic, sedative, hypnotic, and muscle relaxant effects. Flubrotizolam functions by binding to the GABA-A receptor, enhancing the effects of the neurotransmitter GABA, leading to increased inhibitory activity in the brain. It has been used recreationally, but its safety and potential for abuse are concerns. As with other benzodiazepines, it carries risks of dependence, tolerance, and withdrawal symptoms with prolonged use.
| Catalog Number | I027572 |
| CAS Number | 57801-95-3 |
| Synonyms | Flubrotizolam; |
| Molecular Formula | C15H10BrFN4S |
| Purity | 98% |
| Solubility | To be determined |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| IUPAC Name | 4-bromo-7-(2-fluorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene |
| InChI | InChI=1S/C15H10BrFN4S/c1-8-19-20-13-7-18-14(9-4-2-3-5-11(9)17)10-6-12(16)22-15(10)21(8)13/h2-6H,7H2,1H3 |
| InChIKey | VOZDBDBHBXLWCG-UHFFFAOYSA-N |
| SMILES | CC1=NN=C2N1C3=C(C=C(S3)Br)C(=NC2)C4=CC=CC=C4F |
